TENAX THERAPEUTICS, INC. Quarterly Return On Assets in % from Q4 2011 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Tenax Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q4 2011 to Q3 2024.
  • Tenax Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was 14.2 %, a 88% decline year-over-year.
  • Tenax Therapeutics, Inc. annual Return On Assets for 2023 was 58.3 %, a 73.3% decline from 2022.
  • Tenax Therapeutics, Inc. annual Return On Assets for 2022 was 218 %.
  • Tenax Therapeutics, Inc. annual Return On Assets for 2021 was -581 %, a 301% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 14.2 -104 -88% Jul 1, 2024 Sep 30, 2024
Q2 2024 23.4 -127 -84.5% Apr 1, 2024 Jun 30, 2024
Q1 2024 40.9 -115 -73.8% Jan 1, 2024 Mar 31, 2024
Q4 2023 58.3 -160 -73.3% Oct 1, 2023 Dec 31, 2023
Q3 2023 118 +354 Jul 1, 2023 Sep 30, 2023
Q2 2023 151 +337 Apr 1, 2023 Jun 30, 2023
Q1 2023 156 +368 Jan 1, 2023 Mar 31, 2023
Q4 2022 218 +800 Oct 1, 2022 Dec 31, 2022
Q3 2022 -236 +186 +44% Jul 1, 2022 Sep 30, 2022
Q2 2022 -187 +337 +64.4% Apr 1, 2022 Jun 30, 2022
Q1 2022 -213 +267 +55.7% Jan 1, 2022 Mar 31, 2022
Q4 2021 -581 -436 -301% Oct 1, 2021 Dec 31, 2021
Q3 2021 -422 -107 -33.8% Jul 1, 2021 Sep 30, 2021
Q2 2021 -524 -263 -101% Apr 1, 2021 Jun 30, 2021
Q1 2021 -480 -310 -182% Jan 1, 2021 Mar 31, 2021
Q4 2020 -145 -49.8 -52.3% Oct 1, 2020 Dec 31, 2020
Q3 2020 -315 -191 -153% Jul 1, 2020 Sep 30, 2020
Q2 2020 -261 -122 -88% Apr 1, 2020 Jun 30, 2020
Q1 2020 -170 -23 -15.6% Jan 1, 2020 Mar 31, 2020
Q4 2019 -95.2 +70.5 +42.6% Oct 1, 2019 Dec 31, 2019
Q3 2019 -124 +28.6 +18.7% Jul 1, 2019 Sep 30, 2019
Q2 2019 -139 -5.63 -4.24% Apr 1, 2019 Jun 30, 2019
Q1 2019 -147 -44.8 -43.7% Jan 1, 2019 Mar 31, 2019
Q4 2018 -166 -99.7 -151% Oct 1, 2018 Dec 31, 2018
Q3 2018 -153 +85.8 +35.9% Jul 1, 2018 Sep 30, 2018
Q2 2018 -133 -5.17 -4.05% Apr 1, 2018 Jun 30, 2018
Q1 2018 -102 -17.6 -20.7% Jan 1, 2018 Mar 31, 2018
Q4 2017 -66.1 +15 +18.5% Oct 1, 2017 Dec 31, 2017
Q3 2017 -239 Jul 1, 2017 Sep 30, 2017
Q2 2017 -128 Apr 1, 2017 Jun 30, 2017
Q1 2017 -84.9 Jan 1, 2017 Mar 31, 2017
Q4 2016 -81.1 Oct 1, 2016 Dec 31, 2016
Q3 2015 -16.7 +9.28 +35.7% Jul 1, 2015 Sep 30, 2015
Q2 2015 -17.4 +17.6 +50.3% Apr 1, 2015 Jun 30, 2015
Q1 2015 -13.8 +43 +75.8% Jan 1, 2015 Mar 31, 2015
Q4 2014 -21.7 +71.1 +76.7% Nov 1, 2014 Jan 31, 2015
Q3 2014 -26 +218 +89.4% Aug 1, 2014 Oct 31, 2014
Q2 2014 -34.9 +171 +83.1% May 1, 2014 Jul 31, 2014
Q1 2014 -56.8 +196 +77.5% Feb 1, 2014 Apr 30, 2014
Q4 2013 -92.8 +164 +63.8% Nov 1, 2013 Jan 31, 2014
Q3 2013 -244 +78 +24.2% Aug 1, 2013 Oct 31, 2013
Q2 2013 -206 +127 +38.1% May 1, 2013 Jul 31, 2013
Q1 2013 -253 +49.9 +16.5% Feb 1, 2013 Apr 30, 2013
Q4 2012 -257 -46.8 -22.3% Nov 1, 2012 Jan 31, 2013
Q3 2012 -322 Aug 1, 2012 Oct 31, 2012
Q2 2012 -333 May 1, 2012 Jul 31, 2012
Q1 2012 -303 Feb 1, 2012 Apr 30, 2012
Q4 2011 -210 Nov 1, 2011 Jan 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.